Saturday, 9 April 2011

Alexion Submits Applications For Soliris(R) (Eculizumab) As A Treatment For Patients With Atypical Hemolytic Uremic Syndrome (aHUS) In The US And EU

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)